BG103348A - Derivatives of 3-alkoxy-isoxazol-4-yl-substituted 2-amino-carboxylic acids - Google Patents
Derivatives of 3-alkoxy-isoxazol-4-yl-substituted 2-amino-carboxylic acidsInfo
- Publication number
- BG103348A BG103348A BG103348A BG10334899A BG103348A BG 103348 A BG103348 A BG 103348A BG 103348 A BG103348 A BG 103348A BG 10334899 A BG10334899 A BG 10334899A BG 103348 A BG103348 A BG 103348A
- Authority
- BG
- Bulgaria
- Prior art keywords
- group
- alkyl
- hydrogen
- derivatives
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK109296 | 1996-10-04 | ||
PCT/DK1997/000426 WO1998015542A1 (en) | 1996-10-04 | 1997-10-03 | 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BG103348A true BG103348A (en) | 1999-11-30 |
Family
ID=8100908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG103348A BG103348A (en) | 1996-10-04 | 1999-03-20 | Derivatives of 3-alkoxy-isoxazol-4-yl-substituted 2-amino-carboxylic acids |
Country Status (26)
Country | Link |
---|---|
US (1) | US6200999B1 (no) |
EP (1) | EP0934286B1 (no) |
JP (1) | JP2001501630A (no) |
KR (1) | KR20000048908A (no) |
CN (1) | CN1238766A (no) |
AR (1) | AR008880A1 (no) |
AT (1) | ATE230734T1 (no) |
AU (1) | AU733004B2 (no) |
BG (1) | BG103348A (no) |
BR (1) | BR9712198A (no) |
CA (1) | CA2268028C (no) |
CZ (1) | CZ116899A3 (no) |
DE (1) | DE69718338T2 (no) |
EA (1) | EA001625B1 (no) |
ES (1) | ES2189978T3 (no) |
HU (1) | HUP0000084A3 (no) |
IL (1) | IL129135A0 (no) |
IS (1) | IS5009A (no) |
NO (1) | NO312961B1 (no) |
NZ (1) | NZ334798A (no) |
PL (1) | PL332553A1 (no) |
SK (1) | SK42899A3 (no) |
TR (1) | TR199900724T2 (no) |
UA (1) | UA52698C2 (no) |
WO (1) | WO1998015542A1 (no) |
ZA (1) | ZA978877B (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA73749C2 (en) * | 1999-11-01 | 2005-09-15 | Diarylenines | |
ZA200301696B (en) * | 2000-09-15 | 2004-04-28 | Vertex Pharma | Isoxazoles and their use as inhibitors of erk. |
US20040106794A1 (en) * | 2001-04-16 | 2004-06-03 | Schering Corporation | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
UA78529C2 (en) | 2001-10-10 | 2007-04-10 | Wyeth Corp | Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain |
US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
US7253153B2 (en) | 2003-04-09 | 2007-08-07 | Wyeth | Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof |
TW200514775A (en) | 2003-10-22 | 2005-05-01 | Wyeth Corp | Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof |
AU2006301376A1 (en) * | 2005-10-11 | 2007-04-19 | F. Hoffmann-La Roche Ag | Isoxazole derivatives |
WO2009092324A1 (en) * | 2008-01-16 | 2009-07-30 | Hong Kong University Of Science And Technology | Oxazolidine derivatives as nmda antagonists |
EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
TW201609719A (zh) * | 2014-05-28 | 2016-03-16 | 美國禮來大藥廠 | 作為TARP-γ8依賴性AMPA受體拮抗劑之6-經取代-3H-1,3-苯并噻唑-2-酮化合物 |
CN108473431B (zh) * | 2016-01-21 | 2021-08-10 | 阿格罗-金正株式会社 | 2-氨基烟酸苄酯衍生物的制造方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0456519T3 (da) | 1990-05-11 | 1994-11-07 | Sankyo Co | Piperidyloxy- og quinuclidinyloxyisoxazolderivater, deres fremstilling og deres terapeutiske anvendelse |
DE69325662T2 (de) | 1992-10-23 | 2000-02-10 | Merck Sharp & Dohme Ltd., Hoddesdon | Dopamin rezeptor subtyp liganden |
DK124393D0 (da) * | 1993-11-03 | 1993-11-03 | Lundbeck & Co As H | Compounds |
-
1997
- 1997-03-10 UA UA99042300A patent/UA52698C2/uk unknown
- 1997-10-03 IL IL12913597A patent/IL129135A0/xx unknown
- 1997-10-03 KR KR1019990702938A patent/KR20000048908A/ko not_active Application Discontinuation
- 1997-10-03 EP EP97942821A patent/EP0934286B1/en not_active Expired - Lifetime
- 1997-10-03 BR BR9712198-3A patent/BR9712198A/pt unknown
- 1997-10-03 ES ES97942821T patent/ES2189978T3/es not_active Expired - Lifetime
- 1997-10-03 CA CA002268028A patent/CA2268028C/en not_active Expired - Fee Related
- 1997-10-03 TR TR1999/00724T patent/TR199900724T2/xx unknown
- 1997-10-03 AU AU44517/97A patent/AU733004B2/en not_active Ceased
- 1997-10-03 AT AT97942821T patent/ATE230734T1/de not_active IP Right Cessation
- 1997-10-03 EA EA199900358A patent/EA001625B1/ru not_active IP Right Cessation
- 1997-10-03 PL PL97332553A patent/PL332553A1/xx unknown
- 1997-10-03 SK SK428-99A patent/SK42899A3/sk unknown
- 1997-10-03 CZ CZ991168A patent/CZ116899A3/cs unknown
- 1997-10-03 DE DE69718338T patent/DE69718338T2/de not_active Expired - Fee Related
- 1997-10-03 JP JP10517096A patent/JP2001501630A/ja active Pending
- 1997-10-03 US US09/269,356 patent/US6200999B1/en not_active Expired - Fee Related
- 1997-10-03 CN CN97180167A patent/CN1238766A/zh active Pending
- 1997-10-03 ZA ZA9708877A patent/ZA978877B/xx unknown
- 1997-10-03 AR ARP970104586A patent/AR008880A1/es not_active Application Discontinuation
- 1997-10-03 HU HU0000084A patent/HUP0000084A3/hu unknown
- 1997-10-03 NZ NZ334798A patent/NZ334798A/en unknown
- 1997-10-03 WO PCT/DK1997/000426 patent/WO1998015542A1/en not_active Application Discontinuation
-
1999
- 1999-03-20 BG BG103348A patent/BG103348A/xx unknown
- 1999-03-23 IS IS5009A patent/IS5009A/is unknown
- 1999-03-30 NO NO19991561A patent/NO312961B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0934286B1 (en) | 2003-01-08 |
DE69718338T2 (de) | 2003-10-16 |
ATE230734T1 (de) | 2003-01-15 |
KR20000048908A (ko) | 2000-07-25 |
NO991561L (no) | 1999-06-04 |
AU733004B2 (en) | 2001-05-03 |
HUP0000084A3 (en) | 2001-12-28 |
CA2268028A1 (en) | 1998-04-16 |
NO312961B1 (no) | 2002-07-22 |
ZA978877B (en) | 1998-04-17 |
CN1238766A (zh) | 1999-12-15 |
AR008880A1 (es) | 2000-02-23 |
EA199900358A1 (ru) | 1999-10-28 |
IL129135A0 (en) | 2000-02-17 |
SK42899A3 (en) | 1999-08-06 |
DE69718338D1 (de) | 2003-02-13 |
ES2189978T3 (es) | 2003-07-16 |
PL332553A1 (en) | 1999-09-13 |
CA2268028C (en) | 2003-03-18 |
UA52698C2 (uk) | 2003-01-15 |
NZ334798A (en) | 2000-06-23 |
IS5009A (is) | 1999-03-23 |
AU4451797A (en) | 1998-05-05 |
TR199900724T2 (xx) | 1999-06-21 |
EP0934286A1 (en) | 1999-08-11 |
NO991561D0 (no) | 1999-03-30 |
JP2001501630A (ja) | 2001-02-06 |
WO1998015542A1 (en) | 1998-04-16 |
BR9712198A (pt) | 1999-08-31 |
HUP0000084A2 (hu) | 2000-06-28 |
EA001625B1 (ru) | 2001-06-25 |
CZ116899A3 (cs) | 1999-09-15 |
US6200999B1 (en) | 2001-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG103348A (en) | Derivatives of 3-alkoxy-isoxazol-4-yl-substituted 2-amino-carboxylic acids | |
SG165987A1 (en) | Substituted benzoxazoles and analogues as estrogenic agents | |
NZ310850A (en) | 3 alpha hydroxy(17)-unsubstituted derivatives of androstane and 21 substituted derivatives of the pregnane series and medicaments | |
HU9700579D0 (en) | Novel prodrug for treating tumors and flogistic diseases | |
AU1823895A (en) | Xanthine derivative | |
AU1909800A (en) | Microturbine power generating system including a battery source for supplying startup power | |
NZ298296A (en) | Imidazo[4,5-c]quinoline amines; medicaments to induce interferon biosynthesis | |
IL131172A0 (en) | 1-Phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands (d4) | |
CA2284737A1 (en) | [1,2,4]triazolo[1,5-c]pyrimidine derivatives | |
ATE244141T1 (de) | Verfahren und vorrichtung zur kompensation der drehschwingungen einer druckmaschine | |
MX9801488A (es) | Agentes de filtracion de luz. | |
DE50002708D1 (de) | Kupplungssystem für den Anschluss maschinenseitiger Versorgungsleitungen für Medien aller Art inkl. elektrischer Leitungen zwischen Werkzeugmaschinen und daran angekoppeltem Werkstückträger | |
AU2001250404A1 (en) | Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system | |
EP0918259A3 (en) | Electrophotographic photosensitive member, and process cartridge and electrophotographic apparatus having the electrophotographic photosensitive member | |
EP1088702A3 (en) | Apparatus for controlling power supply for use in motor vehicle | |
SE9702928L (sv) | Stöd till pensel | |
WO1998049998A3 (de) | Verwendung von glykosidischen siliconverbindungen zur herstellung von kosmetischen und/oder pharmazeutischen zubereitungen | |
ZA952732B (en) | Process for the preparation of 7-hydroxytaxanes | |
AU7522298A (en) | Use of sulfonyloxadiazolones as microbicides | |
EP0985340A3 (en) | Cleaning machine | |
AU2178199A (en) | Azetidinecarboxamide derivatives for the treatment of cns disorders | |
GB9929582D0 (en) | Chemical compounds | |
HUP9901165A2 (hu) | Idegvédő aktivitású tiamorfinánok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
EP1215951A3 (en) | Method and apparatus for controls of large-area ground plane potentials | |
EP1008596A3 (en) | Silylating agent |